Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Fitoterapia
|
July 13, 2010
Antipruritic activity of extracts of Humulus scandens, the combinations of bioactive flavonoids
Guanzhong Wu, Xin Su
European Journal of Pharmacology
|
November 27, 2012
Genistein: a promising therapeutic agent for obesity and diabetes treatment
Nouredine Behloul, Guanzhong Wu
Renal Failure
|
April 18, 2017
Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update
Qidi Ying, Guanzhong Wu
Platelets
|
May 17, 2014
Antiplatelet aggregation and endothelial protection of I4, a new synthetic anti-diabetes sulfonylurea compound
Lingman Ma, Na Lu, Guanzhong Wu
Pharmaceutical Biology
|
May 10, 2016
Research progress in phytochemistry and biology of Aframomum species
Sarah Wambui Amadi, Yan Zhang, Guanzhong Wu
Bioorganic & Medicinal Chemistry Letters
|
May 5, 2015
De novo design of caseinolytic protein proteases inhibitors based on pharmacophore and 2D molecular fingerprints
Guanzhong Wu, Zhen Zhang, Hong Chen, et al.
Thrombosis Research
|
August 23, 2012
I4, a new synthetic sulfonylurea compound, inhibits the action of TXA2 in vivo and in vitro on platelets and aorta vascular smooth muscle
Na Lu, Minxia Zhan, Cong Gao, et al.
Nutrition Research (New York, N.Y.)
|
October 27, 2009
Antiobesity action of a daidzein derivative on male obese mice induced by a high-fat diet
Yongqi Guo, Guanzhong Wu, Xin Su, et al.
Life Sciences
|
April 3, 2019
Luteolin attenuates high glucose-induced podocyte injury via suppressing NLRP3 inflammasome pathway
Qian Yu, Minda Zhang, Lifen Qian, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
May 7, 2015
Reno-protection of G004, a novel anti-diabetic sulfonylurea in db/db mice
Xiaohui Tong, Haijian Ma, Sarah Wambui Amadi, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Fitoterapia
|
July 13, 2010
Antipruritic activity of extracts of Humulus scandens, the combinations of bioactive flavonoids
Guanzhong Wu, Xin Su
European Journal of Pharmacology
|
November 27, 2012
Genistein: a promising therapeutic agent for obesity and diabetes treatment
Nouredine Behloul, Guanzhong Wu
Renal Failure
|
April 18, 2017
Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update
Qidi Ying, Guanzhong Wu
Platelets
|
May 17, 2014
Antiplatelet aggregation and endothelial protection of I4, a new synthetic anti-diabetes sulfonylurea compound
Lingman Ma, Na Lu, Guanzhong Wu
Pharmaceutical Biology
|
May 10, 2016
Research progress in phytochemistry and biology of Aframomum species
Sarah Wambui Amadi, Yan Zhang, Guanzhong Wu
Bioorganic & Medicinal Chemistry Letters
|
May 5, 2015
De novo design of caseinolytic protein proteases inhibitors based on pharmacophore and 2D molecular fingerprints
Guanzhong Wu, Zhen Zhang, Hong Chen, et al.
Thrombosis Research
|
August 23, 2012
I4, a new synthetic sulfonylurea compound, inhibits the action of TXA2 in vivo and in vitro on platelets and aorta vascular smooth muscle
Na Lu, Minxia Zhan, Cong Gao, et al.
Nutrition Research (New York, N.Y.)
|
October 27, 2009
Antiobesity action of a daidzein derivative on male obese mice induced by a high-fat diet
Yongqi Guo, Guanzhong Wu, Xin Su, et al.
Life Sciences
|
April 3, 2019
Luteolin attenuates high glucose-induced podocyte injury via suppressing NLRP3 inflammasome pathway
Qian Yu, Minda Zhang, Lifen Qian, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
May 7, 2015
Reno-protection of G004, a novel anti-diabetic sulfonylurea in db/db mice
Xiaohui Tong, Haijian Ma, Sarah Wambui Amadi, et al.
Page
of 3